Nutrition researchers have known for many years that omega-3 fatty acids can help reduce the risk of cardiovascular disease (CVD). Yet 95.7 percent of Americans are not consuming enough eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) omega-3 to reach cardioprotective levels. [1] This suboptimal intake is even more concerning when you consider that by 2030, […]
There's little scientific validation behind the multibillion supplement industry - users take pills based on arbitrary whim. Vitagene is building a precision medicine approach - tailoring vitamin regimens to the individual.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
People pop prescription pills with an air of caution, but many look at supplements in a different light: They’re icing on the cake, and who knows? Maybe that echinacea will cure Ebola after all. But many supplements can actually be pretty bad for you, as a recent Business Insider story rightly points out. It cites the […]
In recent days, medical news headlines have been dominated by a new study that linked omega-3 plasma levels to an increased risk of aggressive prostate cancer. Published in the Journal of the National Cancer Institute, results from Dr. Theodore Brasky and colleagues certainly contribute to the evidence-base for omega-3 fatty acids and prostate cancer. Yet […]
NEW YORK (Reuters Health) – Creatine, a supplement favored by bodybuilders, modestly boosted muscle strength in patients with fibromyalgia, Brazilian researchers report. Apart from helping with muscle weakness, though, the treatment had little effect on other symptoms of the mysterious disorder, such as chronic pain, fatigue, memory loss, depression, anxiety and sleeplessness. “The improvements in […]
Energy drinks are in the news again this week as members of Congress call on the companies that make them to provide data about their ingredients and marketing claims. But this isn’t a new conversation. In fact, it’s one that’s been going on for more than 10 years now. And it’s one example of an […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.